Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Avg
|
New words:
Atadja, BioNJ, British, Calgary, chemistry, Clarke, CommBio, Eli, Ghana, Hebrew, Imperial, Innovation, Kumasi, Lilly, Liverpool, organic, passed, Peter, PharmaCyte, Site, superseded, Trafford, UK
Removed:
additionally, auditor, Baptist, compatible, devastating, inadequate, maintaining, Northwestern, rendered, targeted
Filing tables
Filing exhibits
Associated TRAW transcripts
TRAW similar filings
Filing view
External links
Exhibit 31.2
CERTIFICATIONS
I, Mark Guerin, certify that:
1. I have reviewed this Annual Report on Form 10-K/A of Onconova Therapeutics, Inc.; and
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.
Dated: May 1, 2023 |
|
| |
/s/ MARK GUERIN | |
Mark Guerin | |
Chief Operating Officer and Chief Financial Officer | |
(Principal Financial Officer) | |